Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
study ends around
Principal Investigator
by Andrew Krystal, MD (ucsf)Clara Starkweather, MD, PhD (ucsf)
Headshot of Andrew Krystal
Andrew Krystal

Description

Summary

The purpose of this study is to understand how the orbitofrontal cortex (OFC), a region at the front of the brain, guides decisions about whether to pursue a possible reward when doing so also carries a risk of loss, and how this process is altered in depression. People with depression are often less motivated by rewards and more sensitive to potential losses, leading them to avoid situations that others would approach. The OFC is thought to play a central role in these "approach or avoid" decisions, but how it normally does so, and what goes wrong in depression, is not well understood.

This study asks two questions: (1) How does activity in different parts of the OFC signal the decision to approach or avoid? (2) Does this activity differ in people with depression in a way that explains a bias toward avoidance? We hypothesize that the medial OFC (toward the middle of the brain) signals approach, the lateral OFC (toward the side of the brain) signals avoidance, and that in depression the medial OFC signal is weakened, tipping decisions toward avoidance.

Participants are adults who are hospitalized with stereo-EEG (sEEG) electrodes already placed in the brain by their medical team, either to locate the source of seizures in epilepsy or as part of a separate clinical trial for treatment-resistant depression. The electrodes are placed for clinical reasons only, not for this study. During their hospital stay, participants complete a short, game-like computer task (about 20 minutes per session) in which they repeatedly choose whether to approach or avoid options that offer different chances of reward and loss. Their choices and reaction times are recorded along with brain activity from the existing electrodes, and participants rate their mood before each session.

The researchers will compare OFC activity during approach versus avoid decisions, use mathematical models of decision-making to measure how strongly each participant weighs rewards and losses, and compare participants with and without depression. No drugs, devices, or brain stimulation are given as part of this study. The findings are intended to guide the development of more targeted brain-stimulation treatments for treatment-resistant depression.

Official Title

Defining Orbitofrontal Circuit Function in Health and Depression

Keywords

Depression - Major Depressive Disorder, Approach-Avoidance Decision-Making Task, Approach-Avoidance Task During sEEG Monitoring

Eligibility

You can join if…

Open to people ages 18 years and up

All participants:

  • 18 years of age or older
  • Implanted with stereo-EEG (sEEG) depth electrodes, including at least one electrode in the orbitofrontal cortex (OFC)
  • Able to read, write, and provide informed consent

Depressed cohort:

  • Enrolled in the PRESIDIO trial (NCT04004169) of deep brain stimulation for treatment-resistant depression and undergoing inpatient sEEG monitoring as part of that trial
  • Meets DSM-5 criteria for major depressive disorder (single episode of at least 2 years' duration, or recurrent), without psychotic features, confirmed by structured clinical interview (e.g., MINI)

Control (non-depressed) cohort:

  • Undergoing inpatient sEEG monitoring for a clinical indication other than depression (e.g., seizure localization in refractory epilepsy)
  • No current diagnosis of major depressive disorder, confirmed by clinical psychiatric evaluation (e.g., MINI and symptom scales)

You CAN'T join if...

All participants:

  • Current or past DSM-5 diagnosis of a psychotic disorder or major depressive disorder with psychotic features
  • Current or past DSM-5 diagnosis of bipolar or related disorder
  • Current obsessive-compulsive disorder
  • Intellectual disability
  • Autism spectrum disorder
  • Borderline, antisocial, histrionic, or narcissistic personality disorder
  • Impaired decision-making capacity or cognitive deficits that preclude informed consent or task completion
  • Employee of the investigator or study site with direct involvement in the study, or family member of the investigator

Control (non-depressed) cohort only:

  • Epileptiform abnormalities involving the OFC, OFC dysplasia, or prior OFC resection, as determined by clinical evaluation and imaging

Location

  • UCSF accepting new patients
    San Francisco California 94143-2204 United States

Lead Scientists at University of California Health

  • Andrew Krystal, MD (ucsf)
    Dr. Krystal is the Ray and Dagmar Dolby Distinguished Professor in the Departments of Psychiatry and Neurology, Vice-Chair for Research in the Department of Psychiatry, Director of the Dolby Family Center for Mood Disorders, Director of the UCSF Interventional Psychiatry Program and Director of the Clinical and Translational Sleep Research Laboratory.
  • Clara Starkweather, MD, PhD (ucsf)

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07896343
Study Type
Interventional
Participants
Expecting 10 study participants
Last Updated